Boger Laboratory

Alumni - Please Update Info Here

 

Former Graduate Students

Michael D. Mullican, 1984. (University of Kansas) Thesis: "New Aromatic Annulation Methods: Total Synthesis of Juncusol, Sendaverine, and Morphine-Related Analgesics." 1981 A. W. Davidson Award recipient: Outstanding second year graduate student in chemical sciences: Chemistry, Medicinal Chemistry, Pharmaceutical Chemistry, Biochemistry, Chemical Engineering. 1983 Irsay-Dahle Award recipient: Outstanding graduate student in Medicinal Chemistry. 1985 Dorothy Hagland Award recipient: Presented at commencement to the author of the outstanding University of Kansas 1984-85 dissertation. NIH predoctoral trainee, 1981-84. Research Scientist, Parke-Davis/Warner-Lambert Pharmaceutical Company (1984-92). Research Scientist, Vertex Pharmaceutical Company, Cambridge, MA (1992-2002). Senior Director of Chemistry, Neogenesis Pharmaceuticals, Cambridge, MA (2002-2004). Current Position: Senior Searcher, Science IP, CAS Search Services, (2005-present).

James S. Panek, 1984. (University of Kansas) Thesis: "Investigation and Development of Inverse Electron Demand Diels-Alder Reactions of Heterocyclic Azadienes: I. Thermal Cycloaddition of 1,2,4-Triazines, A General Pyridine Annulation; II. Formal Total Synthesis of Streptonigrin; III. Synthetic Studies on Lavendamycin." 1984 Rosenfeld Award recipient: Outstanding graduate student, School of Pharmacy, Univ. Kansas. NIH postdoctoral fellowship, Yale University, Professor S. Danishefsky (1984-86). ACS A. C. Cope Scholar Award, 2002. Current Position: Schmor Professor of Chemistry, Boston University (1986-present).

Christine E. Brotherton-Pleiss, 1985. (University of Kansas) Thesis: "I. Divergent Total Syntheses of Azafluoranthene alkaloids: Rufescine and Imeluteine. II. Scope, Mechanism, and Application of the Cycloaddition Reactions of Cyclopropenone Ketals: Studies on the Total Syntheses of Tropoloalkaloids. III. Formal Total Synthesis of Colchicine." 1982 A. W. Davidson Award recipient: Outstanding second year graduate student in the chemical sciences: Chemistry, Medicinal Chemistry, Biochemistry, Pharmaceutical Chemistry, and Chemical Engineering. 1984 Irsay-Dahle Award recipient: Outstanding graduate student in Medicinal Chemistry. NIH predoctoral trainee, 1982-85. NIH postdoctoral fellowship, University of California, Berkeley, Professor H. Rapoport (1985-87). Research Scientist, Roche Biosciences, Palo Alto, CA (1987-2009); Nutley, NJ (2009-2018). Retired.

Robert S. Coleman, 1987. (Purdue University, Department of Chemistry) Thesis: "Total Synthesis of CC-1065. I. Diels-Alder Reactions of Heterocyclic Azadienes. II. Total Synthesis of PDE-I and PDE-II. III. Total Synthesis of N-Benzenesulfonyl CPI, PDE-I Dimer, and (+)- and (-)-CC-1065. IV. Total Synthesis of (+)- and (-)-CPI-CDPI2 [(+)- and (-)-Deoxy CC-1065]." 1984 A. W. Davidson Award recipient: (University of Kansas, outstanding second year graduate student in chemical sciences: Chemistry, Medicinal Chemistry, Biochemistry, Pharmaceutical Chemistry, and Chemical Engineering). NIH predoctoral trainee, 1985 (University of Kansas). David Ross Fellowship, 1986-87 (Purdue University). NIH postdoctoral fellowship, Yale University, Professor S. Danishefsky (1988-89). Assistant/Associate Professor, University of South Carolina, Columbia, SC (1989-1996). 1989-1994 Dreyfus New Faculty Award. 1991-1993 American Cancer Society New Faculty Research Award. Current Position: Professor Emeritus, Ohio State University (1996-present).

Mona Patel, 1989. (Purdue University, Department of Medicinal Chemistry) Thesis: "I. Diels-Alder Reactions of Heterocyclic Azadienes: Total Synthesis of Prodigiosin, Prodigiosene, and Desmethoxyprodigiosin. II. Preparation of Functionalized Cis-D6-1-octalones: A Probe of Diels-Alder Stereocontrol Utilizing a Rigid Dienophile." Postdoctoral Associate, Princeton University, Professor E. C. Taylor (1989-1991). Research Scientist, Discovery Chemistry, DuPont Pharmaceuticals, Wilmington, DE (1991-2000). Research Scientist, Johnson & Johnson, Raritan, NJ (2000-2006). Current Position: Regulatory Affairs, Cephalon, Raritan, NJ (2007-present)

Ronald J. Wysocki, Jr., 1989. (Purdue University, Department of Chemistry) Thesis: "I. Thermal Cycloaddition Reactions of -Delocalized Singlet Vinylcarbenes. II. [4 + 2] Cycloaddition Reactions of Unactivated 1,3-Oxazinones. III. Total Synthesis and Properties of 1,2,7,7a-Tetrahydrocycloprop[1,2-c]indol-4-one (CI) Analogs of CC-1065." Postdoctoral Associate, NIH, National Cancer Institute, Bethesda, Maryland (1989-1992). Current Position: Senior Scientist, Whitby Research, Richmond, Virginia (1992-present).

Daniel Yohannes, 1991. (Purdue University, Department of Medicinal Chemistry) Thesis: "Isodityrosine Derived Cyclic Peptides: Total Syntheses of L,L-Isodityrosine, K-13, and OF4949-III and OF4949-IV. II. Total Syntheses of Deoxybouvardin and RA-VII and Design, Synthesis and Evaluation of Structural Analogs." Purdue University Cancer Center Fellowship recipient, 1988-1989. NIH Postdoctoral fellowship, Yale University, Professor S. Danishefsky (1991-1993). Research Scientist, Pfizer, Groton, Connecticut (1993-2002). Director, Medicinal Chemistry, Infinity, Cambridge, MA (2002-2003) Director, Medicinal Chemistry, ArQule, Medford MA.(2003-2005), Current Position: Director, Drug Discovery, Targacept Inc., Winston-Salem, NC (2005-present).

Robert J. Mathvink, 1991. (Purdue University, Department of Chemistry) Thesis: "Acyl Radicals: Functionalized Free Radicals for the Construction of Carbocyclic Compounds." Current Position: Research Scientist, Medicinal Chemistry, Merck, Rahway, NJ (1991-2016). Retired.

Irina C. Jacobson, 1991. (Purdue University, Department of Medicinal Chemistry) Thesis: "Studies on the Total Synthesis of Fredericamycin A: Development of an Arylchromium Carbene Complex Benzannulation Approach and Preparation of the Fredericamycin ABDCE Ring System." Research Scientist, DuPont Pharmaceuticals, Wilmington, DE (1991-2001). Current Position: ICOS Inc., Seattle, WA (2001-present).

Subas M. Sakya, 1991. (Purdue University, Department of Chemistry) Thesis: "I. Design, Synthesis, and Evaluation of Functional Analogs of CC-1065. II. Diels-Alder Reactions of Heterocyclic Azadienes. III. Total Synthesis of the Antineoplastic Agent Combretastatin D-2." Research Scientist, Lederle Laboratories, Pearl River, NJ (1991-1997). Current Position: Research Scientist, Pfizer, Groton, CT (1997-present).

Tim T. Curran, 1991. (Purdue University, Department of Chemistry) Thesis: "I. Cycloaddition Reactions of N-Sulfonyl-4-ethoxycarbonyl-1-aza-1,3-butadienes. II. Studies on the Total Synthesis of Rhizoxin and Related Agents: C13-C26 Fragment." David Ross Fellowship recipient, Purdue University, 1990-1991 Research Scientist, Marion Merrell Dow, Cincinnati, OH (1991-1996). Research Scientist, Lederle Laboratories, Pearl River, NJ (1996-1999). Current Position: Research Scientist, Pfizer, Ann Arbor, MI (1999-present).

Hamideh Zarrinmayeh, 1992. (Purdue University, Department of Chemistry) Thesis: "I. Evaluation of the Noncovalent Binding Selectivity of The Antitumor Antibiotic (+)-CC-1065. II. Use of an Alternative Strategy for Generation of Singly 5'-32P End-labeled Double-stranded DNA for Evaluation of the DNA Alkylation Properties of (+)-CC-1065 Functional Analogs. III. Evaluation of the Antitumor Antibiotics, Duocarmycins/Pyrindamycins, and their Functional Analogs. IV. An Alternative Preparation of a Key Intermediate Employed in the Synthesis of the Left-hand Subunit of (+)-CC-1065." Current Position: Research Scientist, Eli Lilly, Indianapolis, Indiana (1992-present).

Royce F. Menezes, 1993. (Purdue University, Department of Chemistry) Thesis: "Design and Synthesis of Bleomycin and Related Agents: DNA Binding and Cleavage Agents." Current Position: Director, Organic Research and Development, EMD Biosciences, San Diego, CA (1993-present).

Carmen M. Baldino, 1993. (Purdue University, Department of Chemistry) Thesis: "Total Synthesis of d,l- and meso-Isochrysohermidin and their DNA Binding Properties." Postdoctoral Associate, Yale University, Professor H. H. Wasserman (1993-95). Director, Chemistry, ArQule, Medford, MA (1995-2006). Current Position: Vice President, Chemistry, BioDuro, Medford, MA (2006-present).

Minsheng Zhang, 1993. (Purdue University, Department of Chemistry) Thesis: "Synthetic Studies on the Natural Antitumor and Antimicrobial Agents: Fredericamycin A, Cis- and Trans-Trikentrin A." Research Scientist, Eli Lilly, Indianapolis, Indiana (1993-1997). Research Scientist, Bristol-Myers Squibb, Princeton, NJ (1997-2003). Current Position: Research Scientist, Wyeth, Princeton, NJ (2003-present).

Weiya Yun, 1994. (Purdue University, Department of Chemistry) Thesis: "Design, Synthesis, and Evaluation of CBI Analogs of CC-1065 and the Duocarmycins." Research Scientist, Berlex Biosciences, Richmond, CA (1994-1996). Current Position: Research Scientist, Hoffmann LaRoche, Nutley, NJ (1996-present).

Yan Zhu, 1995. (TSRI, Department of Chemistry) Thesis: "Studies on the Total Synthesis of Rubrolone." Postdoctoral Associate, University of California, Irvine, CA, Professor S. Rychnovsky (1995-1997). Research Scientist, Genentec, San Francisco, CA (1997-1998). Research Scientist, Advanced Medicine, Inc., San Francisco, CA (1998-2008). Current Position: Research Scientist, Rigel Pharmaceuticals, San Francisco, CA (2008-Present).

J.-H. Chen, 1996. (Purdue University, Department of Chemistry) Thesis: "(-)-Sandramycin and Analogs: Synthesis and Characterization of DNA Binding Properties." Postdoctoral Associate, Yale University, New Haven, CT, Professor H. H. Wasserman (1996-1998). Research Scientist, Ligand Pharmaceuticals, San Diego, CA (1998-2007). Current Position: Director, Synthetic Chemistry, BioDuro, Beijing, China (2007-present)

Christine M. Tarby, 1996. (TSRI, Department of Chemistry) Thesis: "I. The Synthesis and Preliminary Evaluation of the CCBI Alkylation Subunit and Its Extended Agents, Potent CBI-based Analogs of CC-1065. II. The Solution Phase Parallel Synthesis of Combinatorial Libraries." Research Scientist, CombiChem, San Diego, CA (1995-1999). Current Position: Research Scientist, Bristol-Myers Squibb, Princeton, NJ (1999-present).

Jiacheng Zhou, 1996. (TSRI, Department of Chemistry) Thesis: "I. Synthetic Studies on Cycloisodityrosine-Derived Natural Products. II. Design, Synthesis and Evaluation of DNA Affinity Cleavage Agents Based on CC-1065." Research Scientist, DuPont Pharmaceuticals, Wilmington, DE (1996-2002). Group Leader, Rib-X Pharmaceuticals, New Haven, CT (2002-2005). Current Position: Scientist, Incyte, Wilmington, DE (2005-present).

Jonathan Rosenblum, 1996. (TSRI, Department of Molecular Biology, Structural Biochemistry, and Chemistry, Joint with R. Lerner) Thesis: "Creating and Controlling Catalytic Processes." Postdoctoral Research Associate, Rockefeller University (1996-2000). Current Position: Vice President, ActivX Biosciences, La Jolla, CA (2001-present).

Ben F. Cravatt, 1996. (TSRI, Department of Molecular Biology, Structural Biochemistry, and Chemistry, Joint with R. Lerner) Thesis: "I. Antibody-catalyzed Syn Elimination Reaction to Form a Cis Olefin. II. The Chemistry and Biology of 9(Z)-Octadecenamide (Oleamide): A Sleep-inducing Lipid." NSF predoctoral fellowship, 1992-1995. Current Position: Professor and Chair, Department of Chemical Physiology, The Skaggs Institute for Chemical Biology, Helen L. Dorris Child and Adolescent Institute, The Scripps Research Institute, La Jolla, CA (1996-present). Searle Scholar, 1998-2002.

Douglas S. Johnson, 1996. (TSRI, Department of Chemistry) Thesis: "Design and Evaluation of Sequence Selective DNA Binding Agents Based on Duocarmycin SA." ACS Organic Division Graduate Fellowship, 1993-1994 Eli Lilly Fellowship, 1995-1996. NIH Postdoctoral Fellowship, Harvard University, Professor D. A. Evans (1996-1998). Current Position: Research Scientist, Cambridge, MA (1999-present).

Nancy-Ellen Haynes, 1996. (TSRI, Department of Chemistry) Thesis: "Design and Synthesis of Inhibitors of Glycinamide Ribonucleotide Transformylase." Genesia Fellowship, 1993. ACS Medicinal Chemistry Division Graduate Fellowship, 1994-1995. Current Position: Research Scientist, Hoffmann LaRoche, Nutley, NJ (1996-present).

Jean Patterson, 1997. (TSRI, Department of Chemistry) Thesis: "Chemical and Structural Studies on Analogs of Oleamide, an Endogenous Sleep-inducing Lipid." Research Scientist, ArQule, Medford, MA (1997-2006). Current Position: Senior Applications Scientist, Inforsense, Medford, MA (2006-present)

Hui Cai, 1999. (TSRI, Department of Chemistry) Thesis: "I. Design and Evaluation of Functional Analogs of CC-1065 and the Duocarmycins. II. Mechanistic Probes of Bleomycin-DNA Interactions. III. Mechanistic Probes of GAR Tfase Activity and Its Inhibition." Research Scientist, The R. W. Johnson Pharmaceutical Research Institute, La Jolla, CA (1999-2008).Current Position: Vice President, Corporate Development, WuXi, San Diego, CA (2008-Present).

Bryan M. Lewis, 1999. (TSRI, Department of Chemistry) Thesis: "I. Determination of the Relative and Absolute Stereochemistry of Fostriecin. II. Studies Toward the Total Synthesis of Fostriecin." Current Position: Director, Portfolio Strategy and Integration at Bristol Myers Squib (2019-Present).

Robert Garbaccio, 1999. (TSRI, Department of Chemistry) Thesis: "Synthesis and Evaluation of Key Analogs of CC-1065 and the Duocarmycins." 1997 Roche Award for Excellence in Organic Chemistry, 1997-98 ACS Organic Division Fellowship, 1997 Outstanding Presentation Award, TSRI Retreat, 1998-1999 Eli Lilly Graduate fellowship. NIH Postdoctoral Fellowship, Sloan-Kettering Institute for Cancer Research, Professor S. J. Danishefsky (1999-2001). Current Position: Research Scientist, Merck, West Point, PA (2001-present).

Chris Boyce, 1999. (TSRI, Department of Chemistry) Thesis: "I. Selective Metal Cation Activation of a DNA Alkylating Agent: Synthesis and Evaluation of CPyI. II. Total Synthesis of Ningalin A Utilizing a Heterocyclic Azadiene Diels-Alder Reaction." 1998-99 ACS Medicinal Chemistry Division Fellowship. Current Position: Research Scientist, Merck, Kenilworth, NJ (1999-present).

Joel Goldberg, 2000. (TSRI, Department of Chemistry) Thesis: "I. Solution Phase Synthesis of Biaryl Libraries. II. Identification of a Class of Small Molecules which Disrupt Angiogenesis by Blocking the Interaction of Proteinase MMP2 and Integrin alpha v beta 3." 1995-1998 NDSEG Fellowship. Research Associate, International NSF Postdoctoral Fellow, Swiss Federal Institute of Technology - Eidgenossiche Technische Hochschule, Zurich, Switzerland, D. Hilvert (2000-2002). Research Scientist, Rib-X, New Haven, CT (2002-2005). Current Position: Research Scientist, Wyeth, Collegeville, PA (2005-Present).

Steve Castle, 2000. (TSRI, Department of Chemistry) Thesis: "Total Synthesis of the Vancomycin Aglycon and Related Compounds." NSF Predoctoral Fellowship, 1995-1998. NIH Postdoctoral Fellowship, University of California, Irvine, Professor L. E. Overman (2000-2002). Current Position: Professor, Brigham Young University (2002-present).

David S. Lewy, 1998-2001. (TSRI, Department of Chemistry). Deceased.

Jiyong Hong, 2001. (TSRI, Department of Chemistry). Thesis: "Application of Inverse Electron Demand Diels-Alder Reactions in Total Syntheses of Nothapodytine B, (-)-Mappicine, Phomazarin, and ent-(-)-Roseophilin." Bristol-Myers Squibb Graduate Fellowship in Synthetic Organic Chemistry, 2000-2001. Postdoctoral Associate, The Scripps Research Institute, Professor P. G. Schultz (2001-2004). Current Position: Professor, Department of Chemistry, Duke University, Durham, NC (2005-Present). 

Gordon D. Wilkie, 2002. (TSRI, Department of Chemistry). Thesis: "Part I. 1,3,4-Oxadiazoles in Tandem Diels-Alder, 1,3-Dipolar Cycloaddition Reactions: A Rapid Synthesis of Vinca Alkaloid Motifs. Part II. Exceptionally Potent Inhibitors of Fatty Acid Amide Hydrolase." William and Sharon Bauce Family Fellowship, 1997-2002. Research Scientist, Eisai Research Institute, Andover, MA (2002-2011). Process Chemist, Eisai Research Institute, 2002-2011; Process Chemist, Forum Pharmaceuticals (2011-2016). Current Position: Director, Process Chemistry R&D, Blueprint Medicines (2016-Present). 

Scott E. Wolkenberg, 2003. (TSRI, Department of Chemistry). Thesis: "Part I. Applications of Inverse Demand Diels-Alder Reactions of Heterocyclic Azadienes: Two Syntheses of Amaryllidaceae Alkaloids. Part II. In situ Activation of a DNA Alkylating Agent: Evaluation of Simplified and Reversed CPyI Analogues of CC-1065 and the Duocarmycins." ARCS Foundation Fellowship, ACS Division of Organic Chemistry Graduate Fellowship, 2001-2002. Current Position: Research Scientist, Merck, West Point, PA (2003-present).

Danielle R. Soenen, 2003. (TSRI, Department of Chemistry). Thesis: "Studies of Hetereocyclic Diels-Alder Cycloadditions, Total Syntheses of Ningalin B, and Discovery of a New Class of Potent Multidrug Resistant Reversal Agents." ARCS Foundation Fellowship, Bristol-Myers Squibb Graduate Fellowship in Synthetic Organic Chemistry, 2001-2002. Research Scientist, Scion Pharmaceuticals, Medford, MA (2003-present). Current Position: Editorial Assistant, Organic Reactions, Irvine, CA (2006-present)

Winston C. Tse, 2003. (TSRI, Department of Chemistry). Thesis: "Exploring Small-Molecule-DNA Recognition Through the Use of a Fluorescent Intercalator Displacement Assay and Structural Analogues of Bleomycin A2." ACS Division of Medicinal Chemistry Graduate Fellowship, 2002-2003. Research Scientist, Gilead Sciences, Inc., Foster City, CA (2003-2018). Current Position: Senior Director & Head of Chemistry, Vir Biotechnology, Inc., San Francisco, CA (2019-Present).

Paul J. Krenitsky, 2003. (TSRI, Department of Chemistry). Thesis: "Studies on the Total Synthesis and Structure Determination of RP 66453." Current Position: Research Scientist, Vertex Pharmaceuticals, Inc., San Diego, CA (2003-present).

Jeff Zimpleman, M.Sc., 2004. (TSRI, Department of Chemistry). Thesis: "I. Diels-Alder Reactivity of a Novel Dibenzoyl Tetrazine. II. Progress Towards a Total Synthesis of Ningalin D." Current Position: Business Student, The Johnson School of Management, Cornell University (2004-2007). Deceased.

Kevin Capps, 2005. (TSRI, Department of Chemistry). Thesis: "I. Discovery of Novel AICAR Tfase Inhibitors. II. Synthesis of a Pyrrolidine-3, 4-dicarboxamide Library." William and Sharon Bauce Family Fellowship 2001-2005.

David Kastrinsky, 2005. (TSRI, Department of Chemistry). Thesis: "Synthesis of CC-1065 and Duocarmycin Analogues." Current Position: Postdoctoral Fellow, National Institutes of Health (2005-present).

Brendan Crowley, 2005. (TSRI, Department of Chemistry). Thesis: "I. Total Synthesis of the Ristocetin Aglycon. II. Total and Semisynthetic Analogs of the Vancomycin Aglycon Effective Against Vancomycin Resistant Bacteria." Fletcher Jones Foundation Fellowship, 2003-2004. Bristol-Myers Squibb Graduate Fellowship in Synthetic Organic Chemistry, 2004-2005. Postdoctoral Fellow, Sloan-Kettering Institute for Cancer Research (S. Danishefsky), New York, NY (2005-2008). Current Position: Associate Principal Scientist, Merck, West Point, PA (2008-present)

John Trzupek, 2006. (TSRI, Department of Chemistry). Thesis: "Part I: Efficient Synthesis of the DEF Ring System of Complestatin. Part II: Alkylation Properties of (+)- and ent-(?)-Yatakemycin in Protein-Free DNA and in Nucleosome Core Particles." NDSEG Fellowship, 2002-2005. Postdoctoral Fellow, Sloan-Kettering Institute for Cancer Research (S. Danishefsky), New York, NY (2006-2007). Current Position: Research Scientist, Wyeth, Cambridge, MA (2008-present)

Mark Tichenor, 2007. (TSRI, Department of Chemistry). Thesis: "Total Synthesis of Yatakemycin: Structure Revision, Analogue Studies, and Biological Properties." ACS Organic Division Fellowship, 2003-2007. Current Position: Research Scientist, Johnson & Johnson Pharmaceutical, La Jolla, CA (2007-present).

Nadia Haq, 2007. (TSRI, Department of Chemistry). Thesis: "Studies Toward the Total Synthesis of Sultriecin.", 2003-2007. B.S., 2003, California Institute of Technology. Current Position: Research Scientist, Exelixis, Inc., San Diego, CA (2007-present).

Houchao Tao, 2007. (TSRI, Department of Chemistry.Thesis: "Extension of 1,3,4-Oxadiazoles chemistry: Study towards the Total Synthesis of Aspidospermidine. Part II: Progress on the Total Synthesis of Rebeccamycin" Current Position: Postdoctoral Fellow, NIH, Bethesda, MD (2007-present).

Jessica DeMartino, 2008. (TSRI, Department of Chemistry). Thesis: "Synthesis and Evaluation of Inhibitors of Glycinamide Ribonuecleotide Transformylase and Fatty Acid Amide Hydrolase" Current Position: Policy Fellow, National Comprehensive Cancer Network, Fort Washington, PA (2008-present).

Sangyeul Lee, 2008. (TSRI, Department of Chemistry). Thesis: "Chlorofusin: Total Synthesis, Stereochemical Reassignment, Determination of Absolute Configuration, and the Synthesis of Seven Chromophore Analogs" Current Position: Senior Manager, Taejoon Pharmaceuticals, Gyeonggi-Do, Korea (2008-present).

Ryan Clark, 2008. (TSRI, Department of Chemistry). Thesis: "I. An Asymmetrical Variant of the 1-Azadiene Diels-Alder Reaction II. Total Synthesis, Stereochemical Reassignment and Absolute Configuration of Chlorofusin" Current Position: Senior Scientist, Amira Pharmaceuticals, San Diego, CA (2008-present).

Corin Slown, 2008. (TSRI, Department of Chemistry). Thesis: "Studies Toward Understanding the Mechanism of Bleomycin: Total Synthesis of 15N-labeled Bleomycin" Research Scientist, Materia, Pasadena, CA (2008-2010). Current Position: Lecturer, Cal. State Univ., Monterey, CA (2015-present)

Martin Schnermann, 2008. (TSRI, Department of Chemistry). Thesis: "I. Total Synthesis of Piericidin A1 and B1 and Key Analogues II. Studies Towards the Total Synthesis of Vinblastine and Velbanamine Aryl Analogues" Postdoctoral Fellow (2008-2012), L. Overman (UC Irvine). Current Position: Investigator, NCI, Fredrick, MD (2012-present).

Karen MacMillan, 2009. (TSRI, Department of Chemistry). Thesis: "Synthesis and Evaluation of Novel DNA Alkylators: Duocarmycin SA and Yatakemycin Analogues" Current Position: Assistant Instructor, Medicinal Chemistry Core Facility, University of Texas Southwestern Medical Center, Dallas, TX (2009-present).

Joie Garfunkle, 2009. (TSRI, Department of Chemistry). Thesis:"I. Optimization and Analysis of the Central Heterocycle of ?-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase. II. Total Synthesis of Chloropeptin II (Complestatin)." The Gustavus and Louise Pfeiffer Research Foundation Fellowship, 2004-2005, ARCS Fellowship, 2005-2009, Current Position: Senior Research Chemist, Merck, Rahway, NJ (2009-Present).

Paresma "Pinky" Patel, 2010. (TSRI, Department of Chemistry). Thesis:"Intramolecular Cycloadditions of Substituted Cyclopropenone Ketals", ARCS Fellowship, Postdoctoral Fellow, R. Grubbs (California Institute of Technology, 2010-2012). Current Position: FDA (2012-present).

Daisuke Kato, 2011. (TSRI, Department of Chemistry). Thesis:"Asymmetric Total Synthesis of Vindoline and Key Vinblastine Analogs" Current Position: Postdoctoral Fellow, Y. Kishi (Harvard University).

Landon Whitby, 2012. (TSRI, Department of Chemistry). Thesis: "Comprehensive Peptidomimetic Libraries Targeting Protein-Protein Interactions", Postdoctoral Fellow, B. Cravatt (TSRI, 2012-2016). Current Position: Scientist II, Vividon Ther., San diego, CA (2016-present).

James Lajiness, 2012. (TSRI, Department of Chemistry). Thesis: "I. Synthesis and Evaluation of Duorcarmycin Analogues II. Divergent Total Synthesis of (?)-Aspidospermine and (+)-Spegazzinine" Current Position: Medicinal Chemist, GNF, San Diego, CA.

Steven Breazzano, 2013. (TSRI, Department of Chemistry). Thesis: "Synthesis and Stereochemical Determination of Complestatins: Development of a Pd(0)-Mediated Indole (Macro)cyclization Reaction" Current Position: Analyst, Casdin Capital, New York, New York (2018-Present)

Robert James, 2013. (TSRI, Department of Chemistry). Thesis: "Synthesis of Evaluation of Vancomycin Aglycon Analogues: Reengineering Vancomycin for Dual D-Ala-D-Ala and D-Ala-D-Lac Binding' Current Position: Postdoctoral Fellow, R. Linington (University of California, Santa Cruz).

Erin Anderson, 2013. (TSRI, Department of Chemistry), Thesis: "The Scope and Applications of the Inverse Electron Demand Diels-Alder Reactions of 1,2,3-Triazines", Postdoctoral Fellow, M. Schermann (National Cancer Institute), Fredrick, MD. (2013-2018). Current Position: Scientist, Loxo Oncology, Boulder, CO (2018-present).

Amanda L. Wolfe, 2013. (TSRI, Department of Chemistry) Thesis: "Synthesis and Evaluation of Cyclic Seco-CBI-Indole2 Prodrugs and Watersoluble Durcomycin Analogs" Current Position: Assistant Professor Of Chemistry University of North Carolina, Asheville.

Katerina Otrubova, 2013. (TSRI, Department of Chemistry) Thesis: " Rational design of FAAH inhibitors that act by covalently bonding to two active site residues and the design, synthesis and biological activity of serine hydrolase screening libraries." Current Position: Patent Agent, Wilson Sonsini Goodrich & Rosati, San Diego, CA. 

Katie Duncan, 2014. (TSRI, Department of Chemistry) Thesis: "I. alpha-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase: Exploration of Conformational Constraints in the Acyl Side Chain II. In vitro Cytotoxic Activity of Duocarmycin SA and Vinblastine Analogues." Current Position: Scientist, Abide Therapeutics, San Diego, CA.

Justin Sears, 2015. (TSRI, Department of Chemistry) Thesis: "1) New Insights into the Mechanism of the Fe(III)-Promoted Vinblastine Coupling. 2) Next Generation Synthesis of Vindoline via the [4 + 2]/[3 + 2] Cycloaddition Reaction Cascade of an Allene Dienophile." Current Position: Technology Specialist, Fish & Richardson P.C., New York, New York.

Anne F. Kornahrens, 2016. (TSRI, Department of Chemistry, joint with Prof. Timothy Donohoe, Department of Chemistry, University of Oxford) Thesis: "Methodology Development and Synthesis of a Biologically Relevant Natural Product and Targeted Scaffold Discovery for Serine Hydrolase Inhibition." NSF Predoctoral Fellowship 2013-2016. Skaggs-Oxford Scholarship 2011-2016. Current position: 2017-2018 AAAS Science & Technology Fellow, Placed at the NSF in the Math & Physical Sciences Directorate.

Chris Glinkerman, 2018. (TSRI, Department of Chemistry) Thesis: “The Inverse Electron Demand Diels–Alder Reactions of 1,2,3-Triazines: A Powerful Methodology for Heterocycle Synthesis.” NSF Predoctoral Fellowship 2015-2018. Turner B. and Lesly Starr Shelton Endowment Recipient 2016. Current position: 2018-2021 Postdoctoral Associate, J.-K. Weng (The Whitehead Institute).

Jiajun Zhang, 2019. (TSRI, Department of Chemistry) Thesis: "Studies Towards the Divergent Total Synthesis of Vinblastine and Heterocyclic Analogues via a Novel Coupling Protocol." Current Position: 2019-Present, Scientist (Medicinal Chemistry), Enanta Pharmaceuticals, Watertown, MA.

Vyom Shukla, 2019. (TSRI, Department of Chemistry) Thesis: "Synthetic and Medicinal Chemistry of Antitumor Natural Products." Current Position: Manufacturing Scientist, Promega Biosciences, San Luis Obispo, CA, (2019-Present). 

Stephanie Zhou 2019. (M.S., TSRI, Department of Chemistry) 

Kevin Litwin 2021. (TSRI, Department of Chemistry) Thesis: (I. Synthesis and Evaluation of Biologically Active Small Molecules. II. Synthesis of Novel Caspase Inhibitors) , Current Position: Scientist, Tanabe Research Laboratories, San Diego, CA (2021 - present)

Maxwell Moore 2022. (TSRI, Department of Chemistry) Thesis: I. Next-Generation Total Synthesis of Vancomycin and Pocket-Modified Analogues II. Tetrachlorovancomycins: Stereochemical Simplification of the Glycopeptide Antibiotics. Current Position: Medicinal Chemist, Eli Lilly, La Jolla, CA.

Xianhuang Zeng 2022. (TSRI, Department of Chemistry) Thesis: Divergent Syntheses of Three Indole Alkaloids Classes Enabled by a Tandem Cycloaddition Cascade of 1,3,4-Oxadiazole. Current Position: Research Scientist, Gilead Sciences, Foster City, CA. 

Ryan Quiñones 2021. (TSRI, Department of Chemistry) Thesis: 1,2,3-Triazines: Synthesis, Methodology, and Applications. Current Position: Scientist, 1859 Inc., San Diego, CA.

Zhichen Wu 2022. (TSRI, Department of Chemistry) Thesis: Part I. Persistent Positive Charge Modification on Vancomycin. Part II. 1,2,3,5-Tetrazines: General Synthesis and Reactivity. Current Position: Senior Associate Scientist, Amgen, Thousand Oaks, CA.

Zixi Zhu 2023. (TSRI, Department of Chemistry) Thesis: Catalysis and New Reactivities of Azadiene Cycloaddition. Current Position: Scientist, Bristol Myers-Squibb, San Diego, CA.

 

 

Former Postdoctoral Associates and Visiting Scientists

Gunda I. Georg, 1984-85, Ph.D. Univ. Marburg, Germany (M. Haake). Distinguished Professor, Department of Medicinal Chemistry, University of Kansas, Lawrence, Kansas (1985-2006). Current Position: Distinguised Professor and Chair, Department of Medicinal Chemistry, University of Minnesota, (2007-present)

Mark R. Hellberg, 1984-85, Ph.D. Virginia (J. F. Stubbins, R. A. Glennon). Research Scientist, Medicinal Chemistry, A. H. Robins Pharmaceutical Company, Richmond, Virginia (1985-1990). Current Position: Research Scientist, Alcon, Fort Worth, Texas (1990-present).

Steven R. Duff, 1984-85, Ph.D. Univ. of Kansas (R. G. Carlson). Research Scientist, Alcon Labs, Medicinal Chemistry, Allergan, Fort Worth, Texas (1985-1988). Research Scientist, Marion Laboratory, Kansas City, Missouri (1988-1990). Current Position: Research Scientist, Oread Laboratories, Lawrence, Kansas (1990-present).

Masami (Yasuda) Yamaguchi, 1984-87 (Japan), Ph.D. Kyushu Univ. (K. Kanematsu).

Benedict J. Invergo, 1986-87, Ph.D. Northwestern (R. Silverman). Current Position: Research Scientist, Regis Chemical Company, Chicago, Illinois (1988-present).

Kirk D. Robarge, 1986-1988, Ph.D. University of California, Irvine (F. Freeman). Current Position: Research Scientist, Genentec, San Francisco, California (1988-present). Retired.

Takayoshi Ishizaki, 1988-1990, Ph.D. Univ. of Tokyo (K. Shudo). Current Position: Vice President, Director of Research, Kyorin Pharmaceutical Co., Ltd., Tochigi, Japan. Retired.

Shin-suke Nakahara, 1989-1990, Ph.D. Meiji College of Pharmacy (T. Nozoe, A. Kubo). Current Position: Associate Professor, Meiji College of Pharmacy, Tokyo, Japan.

Stephen A. Munk, 1988-1991, Ph.D. University of California, Berkeley (H. Rapoport). American Cancer Society Postdoctoral Fellowship recipient, 1989-1991. Research Scientist and Group Leader, Allergan, Irvine, California (1991-present). President: Ash-Stevens, Inc., Detroit, MI (1997-2017). Current Position: Deputy Director, Arizona State University Biodesign Institute (2017-Present). 

James B. Myers, 1989-1991, Ph.D. Univ. of Ill. (J. C. Martin). NIH Postdoctoral fellowship, 1990-1991. Current Position: Instructor, IUPUI, Indianapolis, Indiana (1991-present).

Kozo Machiya, 1991-1992, Ph.D. 1985, University of Osaka (H. Ueda). Current Position: Research Scientist, Nihon Nohyaku Co., Ltd. (1985-present).

Moorthy Palanki, 1989-1992, Ph.D. Univ. of Kansas (G. Grunewald). Research Scientist, La Jolla Pharmaceuticals, La Jolla, California (1992-1993). Research Scientist, Celgene, San Diego, CA, (1993-2006). Targagen, San Diego, CA (2006-2008). Covax, San Diego, CA (2008-2013).  Current Position: Professor, Cal State Univ. (2018-present).

Yuji Nomoto, 1991-1992, Ph.D. 1991, Hokkaido Univ. (A. Matsuda). Current Position: Research Scientist, Kyowa Haako Kogyo Co., Ltd. (1991-present).

Kenneth Cassidy, 1992-1994, Ph.D. 1992, University of Windsor. (J. McIntosh). Research Scientist, Mann Testing Laboratories, Ltd. (1993-1997). Research Scientist, Rhone-Poulenc Rorer (1997-2000). Current Position: Principle Research Scientist, Eli Lilly and Company (2000-present)

Bradley R. Teegarden, 1991-1993, Ph.D. UCLA (R. Armstrong). Research Scientist, Tanabe Research Laboratories, San Diego, California (1993-2001). Current Position: Research Scientist, Arena Pharmaceutical, San Diego, CA (2001-present)

Wenjin Yang, 1991-1993, Ph.D. 1991, University of California, Riverside (S. Angle). Research Scientist, Gilead Sciences, Foster City, CA (1993-2000). Current Position: Research Scientist, Sunesis, San Francisco, CA (2000-present).

Takeshi Honda, 1991-1993, Ph.D. 1991, University of Tokyo (S. Ikegami). Glaxo Fellowship, 1993-1994. Current Position: Research Scientist, Sankyo Co. Ltd., Tokyo, Japan (1994-present).

Michael Patane, 1992-1994, Ph.D. 1992, USC (N. Petasis). Research Scientist, Merck, West Point, PA (1994-2000). Group Leader, Millenium, Boston, MA (2000-2005). Current Position: Group Leader, Novartis, Boston, MA (2005-present)

Donald Hertzog, 1992-1994, Ph.D. 1992, Emory University (A. Padwa). NIH postdoctoral fellowship, 1992-1994. Research Scientist, Bayer, Pharmaceutical Division, West Haven, CT (1994-1999). Current Position: Research Scientist, Glaxo, Research Triangle Park, NC (1999-present).

Takehide Nishi, 1992-1994, Ph.D. 1990, Hokkaido University (M. Shibasaki). Current Position: Manager, Medicinal Chemistry, Sankyo Co. Ltd., Tokyo, Japan (1990-present).

Steven Colletti, 1992-1994, Ph.D. 1992, Boston University (R. Halterman). NIH postdoctoral fellowship, 1992-1994. Current Position: Research Scientist, Merck, West Point, PA (1994-2018). Senior Vice President, Lodo Therapeutics, New York, NY (2018-present).

Monica Kochanny, 1992-1994, Ph.D. 1992, University of Illinois (J. Katzenellenbogen). NIH postdoctoral fellowship, 1992-1994. Current Position: Research Scientist, Berlex Biosciences, Richmond, CA (1994-present).

Philippe Mesini, 1992-1994, Ph.D. 1992, University Louis Pasteur of Strasbourg (C. Mioskowski). Ligue Nationale Contre Le Cancer fellowship, 1992-93. Current Position: Academic Research Scientist, Centre de Recherche sur les Macromolecules, Strasbourg, France (1995-present).

Ottmar Hueter, 1993-1995, Ph.D. 1993, Universität Basel (B. Giese). Research Scientist, Novartis, Basel, Switzerland (1995-1998). Current Position: Research Scientist, Syngenta, Basel, Switzerland (1998-present).

Kanji Takahashi, 1993-1995. Current Position: Research Scientist, Ono Pharmaceutical Co. Ltd.

Bernd Bollinger, 1994-1995, Ph.D. 1994, Ludwig Maximilian University (P. Gmeiner). Deutsche Forschungsgemeinschaft Fellowship 1994-1995. Current Position: Independent Pharmacist, Munich, Germany (1996-present)

Tsuyoshi Ogiku, 1994-1995, Ph.D. 1992, Osaka University (S. Kusumoto and K. Tomioka). Current Position: Research Scientist, Tanabe Pharmaceuticals, Japan.

Shuji Teramoto, 1994-1996, M. A. 1983, Kyushu University. Ph.D. 1998, University of Tokyo (T. Kitahara). Current Position: Research Scientist, Otsuka Pharmaceutical Co., Japan.

Tim Ramsey, 1994-1996, Ph.D. 1994, Boston University (R. Halterman). Current Position: Executive Director of Oncology Chemistry, Novartis Institutes for Biomedical Research, Cambridge, MA (1996-present).

Marjana Loncar, 1996, B.Sc. 1989, University of Lund. Current Position: Research Scientist, Astra Draco AB, Lund, Sweden (1996-present).

N. Han, 1994-1996, Ph.D. 1991, Columbia University (N. Turro). Current Position: Research Scientist, Amgen, Thousand Oaks, CA (1996-present).

Jeff McKie, 1994-1996, Ph.D. 1994, University of Colorado (G. Molander). NIH postdoctoral fellowship, 1994-1996 Research Scientist, Abbott Laboratories, Abbott Park, IL (1996-1998). Current Position: Director, Medicinal Chemistry, Celgene, San Diego, CA (1998-present).

Tracy Jenkins, 1994-1996, Ph.D. 1994, Memorial University of Newfoundland (J. Burnell). Research Scientist, Amgen, Thousand Oaks, CA (1996-2000). Current Position: Research Scientist, Millenium, Boston, MA (2000-present).

Robert Borzilleri, 1994-1996, Ph.D. 1994, Penn State University (S. Weinreb). NIH postdoctoral fellowship, 1995-1997. Current Position: Research Scientist, Bristol-Myers Squibb, Princeton, NJ (1997-present).

Kurt Saionz, 1994-1996, Ph.D. 1994, University of Illinois (S. Zimmerman). Current Position: Research Scientist, Pharmacopia, Princeton, NJ (1997-present).

Michio Ishida, 1995-1997, Ph.D. 1990, Chiba University (K. Ogura). Current Position: Research Scientist, Central Glass Company, Saitama-ken, Japan (1997-present).

Seiji Nukui, 1995-1997, Ph.D. 1995, University of Tokyo (M. Shibasaki). Current Position: Research Scientist, Pfizer, Chitagun Aichiken, Japan (1997-present).

Mbiya Kapiamba, 1994-1996, Ph.D. 1994, Universite Catholique de Louvain (L. Ghosez). Research Scientist, Eastman Kodak, Rochester, NY (1997-2005). Current Position: Senior Research Scientist, US Surgical, North Haven, CT (2005-present)

Andrea Vaupel, 1996-1997, Ph.D. 1995, University of Marburg (P. Knochel). Current Position: Research Scientist, Bayer AG, Wupertal, Germany (1997-present).

Masataka Hikota, 1996-1997, Ph.D. 1990, Hokkaido University (O. Yonemitsu). Research Scientist, Tanabe Seiyaka Co., Ltd., Saitama, Japan (1997-2007). Current Position: President and CEO, Tanabe Research Laboratories USA, Inc. (2007-present).

Cathryn Shelton, 1996-1997, Ph.D. 1996, The University of Sydney (M. M. Harding). Current Position: Research Associate, School of Biochemistry and Molecular Genetics, Sydney, Australia (1997-present).

Philip Turnbull, 1996-1998, Ph.D. 1996, University of California, Irvine (H. Moore). Current Position: Research Scientist, GlaxoSmithKline, Inc., Research Triangle Park, NC (1998-present).

Young-Sik Jung, 1997-1998, Ph.D. 1989, University of Maryland (P. S. Mariano). Current Position: KRICT, Taejeon, Korea (1998-present).

Gunter Schüle, 1996-1998, Ph.D. 1996, University of Stuttgart (T. Ziegler), Deutsche Forschungsgemeinschaft postdoctoral fellowship, 1996-1997. Research Scientist, Pharmacopia, Princeton, NJ (1998). Current Position: Research Scientist, Novartis Animal Health, Basel, Switzerland (1998-present).

Pierre Ducray, 1997-1999, Ph.D., 1997, University of Strasbourg (C. Mioskowski). Current Position: Group Leader, Novartis Animal Health, Inc., Basel, Switzerland (1998-present).

Wenying Chai, 1996-1998, Ph.D. 1996, University of Kansas (T. Engler). Current Position: Research Scientist, The R. W. Johnson Pharmaceutical Research Institute, La Jolla, CA (1998-present).

Richard T. Beresis, 1996-1998, Ph.D. 1996, Boston University (J. Panek). NIH postdoctoral fellowship, 1996-1998. Research Scientist, Merck Research Laboratories, Rahway, NJ (1998-2009). Current Position: Senior Director, Medicinal Chemistry, ChemPartner, Shanghai, China (2009-present).

Olivier Loiseleur, 1997-1999, Ph.D. 1995, University of Basel (A. Pfaltz), Swiss National Foundation postdoctoral fellowship (1997). Current Position: Research Scientist, Novartis, Basel, Switzerland (1999-present).

Haruhiko Sato, 1997-1999, Ph.D. 1993, Tohoku University (C. Kaneko and M. Somei). Current Position: Research Manager, Chugai Pharmaceutical Co., Ltd., Shizouka, Japan (1999-present).

Mark W. Ledeboer, 1997-1999, Ph.D. 1997, Brown University (K. A. Parker). NIH postdoctoral fellowship, 1997-1999. Current Position: Research Scientist, Vertex, Cambridge, MA (1999-present).

Masaharu Kume, 1998-1999, Ph.D. 1992, Kyoto University (F. Yoneda and Y. Nagao). Current Position: Research Scientist, Shionogi Pharmaceutical Co., Osaka, Japan (1992-present).

Shigeki Satoh, 1998-1999, Ph.D. 1988, Tohoku University (S. Takano and K. Ogasawara). Current Position: Research Manager, Fujisawa Pharmaceutical Co. Ltd., Osaka, Japan (1988-present).

Holger Keim, 1997-1999, Ph.D. 1997, University of Güttingen (L. F. Tietze). Deutsche Forschungsgemeinschaft postdoctoral fellowship, 1997-1998. Current Position: Research Scientist, ArQule, Inc., Medford, MA (1999-present).

René A. Castro, 1997-1999, Ph.D. 1997, University of Miami (A. E. Kaifer). NIH postdoctoral fellowship 1997-1999. Current Position: MBA student, Amos Tuck School of Business Administration, Hanover, NH (1999-present).

Brian M. Aquila, 1997-1999, Ph.D. 1997, The Ohio State University (M. S. Platz). Research Scientist, Sepracor, Inc., Marlborough, MA (1999-2002). Research Scientist, Astra Zeneca, Waltham, MA (2002-2017).  Current Position: Senior Director, Med. Chemistry, Alkermes, Waltham, MA (2017-present).

Lynn O. Resnick, 1997-1999, Ph.D. 1997, Brown University (K A. Parker). Current Position: Research Scientist, Wyeth-Ayerst, Princeton, NJ (1999-present).

Clark A. Sehon, 1997-1999, Ph.D. 1997, University of Virginia (J. A. Marshall). NIH postdoctoral fellowship, 1998-1999. Research Scientist, The R.W. Johnson Pharmaceutical Research Institute, La Jolla, CA (1999-2003). Current Position: Research Scientist, GlaxoSmithKline, Philadelphia, PA (2003-present).

Susumu Miyazaki, 1997-1999, M.S. 1994, Ph.D. 1999, University of Tokyo (M. Shibasaki). Current Position: Research Scientist, Japan Tobacco, Osaka, Japan (1994-present).

Weiqin Jiang, 1997-1999, Ph.D. 1997, The University of Chicago (W. D. Wulff). Research Scientist, The R. W. Johnson Pharmaceutical Research Institute, Raritan, NJ (1999-2008). Current Position: Chemistry Reviewer, Food and Drug Administration, Silver Spring, Maryland (2008-Present).

Richard J. Lee, 1997-1999, Ph.D. 1997, University of Nebraska (P. H. Dussault). Research Scientist, Pfizer, Holland, MI (1999-2004). Current Position: Theravance, San Francisco, CA (2004-present)

Marc Labroli, 1997-1999, Ph.D. 1997, University of Virginia (T. L. Macdonald). Current Position: Research Scientist, Merck, Kenilworth, NJ (1999-present).

Jae Kyoo Lee, 1997-1999, Ph.D. 1997, Johns Hopkins University (G. H. Posner). Current Position: Research Scientist, ArQule, Inc., Medford, MA (1999-present).

Alejandro Santill�n, 1997-1999, Ph.D. 1997, University of Houston (H. Kohn). Current Position: Research Scientist, The R.W. Johnson Pharmaceutical Research Institute, La Jolla, CA (1999-present).

Robert P. Schaum, 1997-1999, Ph.D. 1997, Université de Montréal (S. Hanessian). Current Position: Research Scientist, Pfizer, Ann Arbor, MI (2000-present).

Brian E. Fink, 1997-1999, Ph.D. 1997, University of Illinois (J. Katzenellenbogen). NIH postdoctoral fellowship, 1998-1999. Current Position: Research Scientist, Bristol-Myers Squibb, Princeton, NJ (2000-present).

Mark Searcey, 1997-1999, Senior Lecturer, University of London School of Pharmacy (1999-2006). Chair of Medicinal Chemistry and Head of Schools of Pharmacy and Chemistry, School of Chemical Sciences and Pharmacy, University of East Anglia, UK (2006-2019). Current Position: Pro-Vice Chancellor for Science, University of East Anglia, UK (2019-Present).

Wenge Zhong, 1998-2000, Ph.D. 1998, California Institute of Technology (D. Dougherty). Current Position: Research Scientist, AMGEN, Thousand Oaks, CA (2000-present).

Hongjian Jiang, 1999-2000, Ph.D. 1999, University of Virginia (J. A. Marshall). Current Position: Research Scientist, Albany Molecular Research, Albany, NY (2000-present).

Takayuki Matsuzaki, 1998-2000, M.S. 1989, Tokushima University. Current Position: Research Scientist, Otsuka Pharmaceuticals, Otsuka, Japan (1989-present).

Seong Heon Kim, 1998-2000, Ph.D. 1998, Purdue University (P. L. Fuchs). Research Scientist, Schering-Plough Research Institute, Kenilworth, NJ. Current Position: Executive Director of Chemistry, Boryung Pharmaceuticals (2016-present).

Pierre-Yves Bounaud, 1998-2000, Ph.D. 1998, State University of New York at Stony Brook (I. Ojima). Research Scientist, LG Biomedical Institute, La Jolla, CA (2000-2001). Current Position: Research Scientist, Structural Genomix, San Diego, CA (2001-present).

Yves Ambroise, 1999-2001, Ph.D. 1999, Cea Saclay, Université Paris XI (C. Mioskowski). Current Position: Research Scientist, CEA Seclay, France (2001-present).

Steven R. Brunette, 1999-2001, Ph.D. 1998, Purdue University (M. Lipton). ACS postdoctoral fellowship, 1999-2001. Current Position: Research Scientist, Boehringer-Ingelheim Pharmaceuticals, Ridgefield, CT (2001-present).

Jian-Hui Weng, 1999-2001, Ph.D. 1995, Universite Rene Descartes, Paris, France (B. Roques). Current Position: Research Scientist, Aventis, Tucson, AZ (2001-present).

Yan Chen, 1999-2001, Ph.D. 1999, Boston University (J. K. Snyder). Research Scientist, Theravance, South San Francisco, CA (2001-2008). Current Position: Rigel Pharmaceutical, San Francisco, CA (2008-present).

Satoshi Ichikawa, 1999-2001, Ph.D. 1999, Hokkaido University (A. Matsuda). Current Position: Associate Professor, University of Hokkaido, Japan (2001-present).

Takahiro Ishii, 1999-2001, Ph.D. 1999, Tokushima University (Y. Nagao). Japan Promotion of Science Postdoctoral Fellowship, 1999-2000. Current Position: Research Scientist, Yamanuchi Pharmaceuticals, Kochi, Japan (2001-present).

Carla-Maria Gauss, NIH Postdoctoral Fellow 1999-2001, Ph.D. 1999, University of California, Irvine (A.R. Chamberlin). Research Scientist, X-Ceptor Therapeutics, San Diego, CA (2001-2004). Current Position: Research Scientist, Memory Pharm., Montvale, NJ (2004-present).

Robert A. Fecik, American Cancer Society Postdoctoral Fellow 1999-2001, Ph.D. 1999, University of Kansas (L. A. Mitscher). Current Position: Associate Professor, University of Minnesota (2001-present).

Terry V. Hughes, 1999-2001, Ph.D. 1999, University of Alabama (M. P. Cava). Research Scientist, The R. W. Johnson Pharmaceutical Research Institute, Raritan, NJ (2001-2008). Current Position: Research Scientist, GlaxoSmithKline, Philadelphia, PA (2008-present).

Tom Marsilje, 1999-2001, Ph.D. 1999, SUNY at Buffalo (D. Hangauer). Research Scientist, Millenium Pharmaceuticals, Boston, MA (2001-2003). GNF, La Jolla, CA (2003-2007) Current Position: Pfizer, La Jolla, CA (2007-present)

Hiroshi Miyauchi, 1999-2001, Sumitomo Pharmaceuticals Co.,Ltd., Ph.D. 1996, Hokkaido University (A. Murai). Current Position: Scientist, Sumitomo Pharmaceuticals Co.,Ltd. (1996-present).

Yoshiki Mori, 1999-2001, M.S. 1993 Mitsubishi-Tokyo Pharmaceutical Company, Yokahama, Japan (M. Shibasaki). Current Position: Mitsubishi Pharmaceutical Corporation (1993-present).

Olivier Rogel, 1999-2001, Ph.D. 1999, Université of Montréal (S. Hanessian). Current Position: Research Scientist, Novartis, East Hanover, NJ (2001-present).

David A. Ellis, 1999-2001, Ph.D. 1999, The Ohio State University (D. J. Hart). Current Position: Research Scientist, GNF, La Jolla, CA (2002-present).

Jeff McAtee, NIH Postdoctoral Fellow 1999-2001, Ph.D. 1999, Emory University (D. Liotta). Current Position: Research Scientist, Glaxo Smith Kline, Upper Merrion, PA (2001-present).

Craig R. Woods, 2000-2002, Ph.D. 1998, University of California, San Diego (J. S. Siegel), 1998-1999 ETH-Swiss Federal Institute of Technology, Zurich (F. Diederich). Current Position: Research Scientist, Johnson & Johnson, La Jolla, CA (2002-present).

Harald Schmitt, 2000-2002, Ph.D. 2000, Technical University Munich (H. Kessler, U. Diederichsen). Current Position: Research Scientist, CAG, Munich, Germany (2002-present).

Manjinder S. Lall, AHFMR Postdoctoral Fellow 2000-2002, Ph.D. 2000, University of Alberta (J. C. Vederas). Current Position: Research Scientist, Pfizer, Ann Arbor, MI (2002-present).

Melitta Bilban, Erwin Schroedinger Fellowship from the Austrian Science Foundation 2000-2002, Ph.D. 2000, Novartis Research Institute/Technical University Vienna, Austria (P. Nussbaumer, C. P. Kubicek). Current Position: Research Project Manager, Baxter BioScience, Vienna, Austria (2002-present).

Brian S. J. Blagg, NIH Postdoctoral Fellow 1999-2002, Ph.D. 1999, University of Utah (D. Poulter). Professor, University of Kansas, Lawrence, KS (2002-2017). Current Position: Charles Huisking Professor, University of Notre Dame (2017-present).

Jutta Wanner, 2000-2002, Ph.D. 2000, University of Kansas (T. Engler, R. Carlson). Research Scientist, Eli Lilly, Hamburg, Germany (2002-2003). Current Position:Roche Biosciences, Palo Alto, CA (2003-present).

Joel Desharnais, 2000-2002, Ph.D. 2000, University of Montreal, Canada (J. D. Wuest). Research Scientist, Dihedron, San Diego, CA (2003-2006). Research Scientist, Pfizer, La Jolla, CA (2006-2013). Current Position: Associate Director, Research and Technology, Bioatrica, San Diego, CA (2013-present).

Arkadius Pichota, 2001-2003, Postdoctoral Fellowship of the German Academic Exchange Service (DAAD), Ph.D. 2000, Swiss Federal Institute of Technology - Eidgenossiche Technische Hochschule, Zurich, Switzerland (D. Seebach). Research Scientist, Roche Biosciences, Palo Alto, CA (2003-2004) Current Position: Principal Scientist, Novartis Institute For Tropical Diseases, Singapore (2004-present).

Bryan Yeung, 2001-2003, Ph.D. 2001, University of Illinois at Urbana-Champaign (P. A. Petillo). Research Scientist, Exelixis, San Francisco, CA (2003-2006). Current Position: Principal Scientist, Novartis Institute for Tropical Diseases, Singapore (2006-present).

Casey C. McComas, 2001-2003, Ph.D. 2001, University of California, Irvine (D. L. Van Vranken). Current Position: Research Scientist, Wyeth, Philadelphia, PA (2003-present).

Jay P. Parrish, 2001-2003, Ph.D. 2001, University of South Florida (K. W. Jung). Research Scientist/Corporative Development, Gilead Sciences, Inc., Foster City, CA (2003-2016). Current Position: Vice President, Strategy and Corporate Development, VIB, and Venture Partner, ARCH Venture Partners.

Richard Ducray, 2002-2004, Ph.D. 2002, Université Claude Bernard (M. Ciufolini). Current Position: Research Scientist, France.

Zhongqing Yuan, 2002-2004, Ph.D. 2001, Umea University, Sweden (J. Kihlberg). Current Position: Research Scientist, AstraZeneca, Sweden (2004-present).

Jennifer Blount, 2003-2004, Ph.D. 2003, Boston University (J. Panek), NIH Postdoctoral Fellowship. Current Position: Research Scientist, Millenium Pharmaceuticals, Boston, MA (2004-present).

Suzanne Buck, 2002-2004, Ph.D. 2002, University of Kansas (G. I. Georg). Current Position: Research Scientist, Molecular Probes, Eugene, OR (2004-present).

Pankaj Desai, 2002-2004, Ph.D. 2002, University of Kansas (J. Aube). Current Position: Paralegal, Heller Ehrman White & McAuliffe LLP, Washington, D.C. (2004-present).

Futoshi Shiga, 2003-2004, Current Position: Research Scientist, Kyorin Pharmaceutical Co. Ltd.

Yongkai Li, 2002-2004, Ph.D. 2002, Dartmouth College (P. Jacobi). Current Position: Research Scientist, Ligand, San Diego, CA (2004-present).

Wu Du, 2002-2004, Ph.D. 2002, University of Pittsburgh (D. Curran). Current Position: Senior Research Chemist, Merck, Rahway, NJ (2004-present).

Heng Cheng, 2002-2004, Ph.D. 2000, University of Illinois at Chicago (W. L. Mock), 2000-2002, University of Illinois at Urbana-Champaign (J. Gerlt). Current Position: Research Scientist, Fibrogen, San Francisco, CA (2004-present).

Christophe Hardouin, 2001-2004, Ph.D. 2001, CEA Saclay, Université Paris XI (C. Mioskowski). Current Position: Research Scientist, Servier, France (2004-present)

Yosup Rew, 2002-2004, Ph.D. 2002, University of California San Diego (M. Goodman). Current Position: Research Scientist, Amgen, South San Francisco, CA (2004-present)

Young-Wan Ham, 2002-2004, Ph.D. 2002, Purdue University (J. Chemielewski). Research Scientist, Molecular Therapeutics, Ann Arbor, MI (2004-2006). Assistant Professor, Brigham Young University, Provo, UT (2006-2012) Current Position: Associate professor, Utah Valley Univ. (2012-present).

Romyr Dominique, 2003-2005, Ph.D. 2002, University of Ottawa (R. Roy), NSERC Fellowship. Current Position: Research Scientist, Roche, Nutley, NJ (2005-present)

Steven Pfeiffer, 2003-2005, Ph.D. 2003, University of California, Santa Barbara (B. Lipshutz). Current Position: Research Scientist, Gilead Sciences, Inc., Foster City, CA (2005-present).

Dongwoo Shin, 2002-2004, Ph.D. 2002, University of Illinois (A. Ghosh). Current Position: Research Scientist, Samsung, Inc., South Korea (2005-present).

Youhoon Chong, 2003-2005, Ph.D. 2003, University of Georgia (C. Chu). Current Position: Professor and Chairmen, Konkuk University, South Korea (2005-present).

Younggi Choi, 2003-2005, Ph.D. 2003, Oregon State University (J. White). Current Position: Research Scientist, Boehringer Ingelheim, Danbury, Connecticut (2005-present).

Juraj Velcicky, 2003-2005, Ph.D. 2003, University of Cologne (H.-G. Schmalz). Current Position: Research Scientist, Novartis, Basil, Switzerland (2005-present).

Trinh Nguyen, 2005, University of London School of Pharmacy (M. Searcey).

Sukwon Hong, 2003-2005, Ph.D. 2003, Northwestern University (T. Marks). Assistant Professor, University of Florida, Gainsville, FL (2005-2012). Current Position: Professor and Chair, Guangju Institute of Science and Technology (GIST, 2012-present).

Wooseok Han, 2003-2005, Ph.D. 2003, University of Toronto (M. Lautens). Research Scientist, Novartis, Emeryville, CA (2005-2020). Current Position: Executive Vice President and Chief Scientific Officer, Cyrus Therapeutics, Seoul, South Korea (2020 - present).

Gyungyoun Kim, 2002-2005, Ph.D. 2002, Washington State University (D. Matteson). Current Position: Senior Research Scientist, SK Biophamaceuticals, Fairfield, NJ (2005Executive Vice President and Chief Scientific Officer, Cyrus -present).

Sobhana Babu Boga, 2003-2005, Ph.D. 2000, Indian Institute of Technology (K. K. Balasubramanian), 2000-2003, Université Catholique de Louvain (L. Ghosez). Current Position: Senior Scientist, Schering-Plough, Kenilworth, NJ (2005-present).

Michael Kelso, 2004-2005, Ph.D. 2002, University of Queensland (D. Fairlie). CJ Martin Research Fellow, University of Wollongong, Wollongong, NSW, Australia. Current Position: Professor of Medicinal Chemistry, University of Wollongong, Wollongong, NSW, Australia (2006-Present)

Dan Horne, 2004-2006, Ph.D. 2003, Stanford University (B. Trost). Research Scientist, Amgen, Thousand Oaks, CA. Current Position: Principal Scientist, Sage Therapeutics, Cambridge, MA (2018-Present)

Greg Elliott, 2001-2006, Ph.D. 2001, University of California, Santa Cruz (J. P. Konopelski). Assistant Director of Medicinal Chemistry, John and Rebecca Moore's Cancer Center, UCSD, La Jolla, CA (2006-2007). Assistant Professor, University of Kentucky (2007-2010). Current Position: Adjunct Professor, San Diego Mesa College (2014-present)

Wei Jin, 2004-2006, Ph.D. 2004, Colorado State University (R. Williams). Current Position: Research Associate, China (2006-present)

Jeromy Cottell, 2004-2006, Ph.D. 2004, University of Illinois, Urbana-Champaign (S. Denmark), NIH Postdoctoral Fellowship. Current Position: Research Scientist, Gilead Sciences, Inc., Foster City, CA (2006-present).

Brian Lawhorn, 2004-2006, Ph.D. 2004, Cornell University (T. Begley), NIH Postdoctoral Fellowship. Current Position: Research Scientist, GlaxoSmithKline, King of Prussia, PA (2006-present).

Kevin Bunker, 2004-2006, Ph.D. 2003, University of California at San Diego (J. O'Connor). Current Position: Research Scientist, Pfizer, San Diego, CA (2006-present).

Hiroki Kakuta, 2006, Assistant Professor, Department of Molecular Design for Medicine, Okayama University.

Anthony Romero, 2004-2006, Ph.D. 2004, University of Kansas (G. Grunewald), American Cancer Society Postdoctoral Fellowship. Senior Research Chemist, Merck (2006-2012), Genentech (2012-2017), Unity Biotechnology (2017-2018). Current Position: Director of Medicinal Chemistry, Terns Pharmaceuticals (2018-Present).

Akiyuki Hamasaki, 2004-2006, Ph.D. 2003, Kumamoto University (M. Otsuka). Research Scientist, Unitech, Tokyo, Japan (2006-2007). Current Position: Assistant Professor, Kyushu University, Japan (2008-present).

Hayato Ishikawa, 2004-2007, Ph.D. 2004, Chiba University (H. Takayama). Assistant Professor, Tokyo University of Science, Tokyo, Japan (2007-2011). Current Position: Professor, Kumamoto University, Kumamoto, Japan (2011-Present)

Leo Takaoka, 2005-2007, Ph.D. 2004, University of California, Irvine (S. Rychnovsky). Senior Scientist, Schering-Plough, Boston, MA (2007-2009). Current Position: Millenium, Boston, MA (2009-present)

James Fuchs, 2005-2007, Ph.D. 2005, The Pennsylvania State University (R. Funk). Current Position: Professor, Division of Medicinal Chemistry and Pharmacognosy, The Ohio State University, Columbus, OH (2007-present).

Alex Shaginian, 2005-2007, Ph.D. 2005, University of Wisconsin, Madison (P. Belshaw). Current Position: Research Scientist, Ardea Biosciences, Irvine, CA (2007-present).

Yingchao Zhang, 2005-2007, Ph.D. 2005, The University of Colorado, Boulder (T. Sammakia). Current Position: Research Scientist, Hoffman-LaRoche, Nutley, NJ (2007-present).

Chris Liu, 2005-2007, Ph.D. 2005, University of Michigan (W. Roush). Current Position: Research Scientist, Cubix Pharmaceuticals, Lexington, MA (2008-present).

Hiroyuki Kakei, 2007-2008, Ph.D. 2007, University of Tokyo (M. Shibasaki). Current Position: Researcher, Takeda Pharmaceutical Company Ltd., Ibaraki, Japan.

Jan Elsner, 2006-2008, Ph.D. 2006, Friedrich Alexander University, Erlangen-Nuernberg, Germany (P. Gmeiner). Current Position: Research Scientist, Celgene Pharmacetuicals, San Diego, CA (2008-present).

Joonwoo Nam, 2004-2008, Ph.D. 2004, Princeton University (D. Kahne). Current Position: Research Scientist, CytRx Corporation, San Diego, CA (2008-present).

David A. Colby, 2006-2008, Ph.D. 2006, University of California, Irvine (A. R. Chamberlin). Assistant Professor, Purdue University, West Lafayette, IN (2008-2014). Current Position: Associate Professor, Medicinal Chemistry, Univ. of Mississippi (2014-present)

Yoshio Ando, 2007-2008, Ph.D. 2007, Tokyo Institute of Technology (T. Takahashi) Current Position: Assistant Professor, Tokyo Institute of Technology, Japan (2008-Present).

Shinobu Takizawa, 2006-2008, Ph.D. 2007, Osaka University (H. Sasai) Current Position: Assistant Professor, Osaka University, Japan (2008-Present)

Shigeki Seto, 2007-2008, Visiting Scientist, Kyorin Pharmaceuticals Current Position: Senior Researcher, Kyorin Pharmaceuticals Co., Japan.

James Stover, 2006-2008, Ph.D. 2006, Vanderbilt University (C. J. Rizzo) Current Position: Senior Research Scientist, Genzyme, Cambridge, MA (2008-Present)

Scott Kimball, 2005-2007, Ph.D. 2005, University of Kansas (G. Georg). Current Position: Senior Scientist, Osteogenex, Kansas City, KS (2009-present).

Shinobu Takizawa, 2006-2008, Current Position: Assistant Professor, The Institute of Scientific and Industrial Research, Osaka University (2008-Present).

Haibo Ge, 2006-2008, Ph.D. 2006, University of Kansas (G. Georg). Associate Professor, ILLPLLI, Indianapolis, IN (2009-2019). Current Position: Professor, Texas Tech University (2019-present)

Porino Va, 2007-2009, Ph.D. 2007, The Scripps Research Institute, Florida (W. Roush). Current Position: Research Investigator I, GNF, San Diego, CA (2009-present).

Hiroyuki Shimamura, 2008-2010, Ph.D. 2008, Kitasato University (T. Sunazuka). Current Position: Chugai Pharmaceuticals Lo., Ltd. (2010-present)

Erica Campbell, 2009-2011, Ph.D. 2008, The Ohio State University (R. Coleman). Current Position: Research Scientist, Vertex Pharmaceuticals, San Diego, CA (2010-present)

Chris Burke, 2007-2009, Ph.D. 2007, Colorado State University (Y. Shi). Current Position: Genomics Institute of the Novartis Research Foundation, La Jolla, CA (2010-present)

Simon Stamm, 2006-2008,Ph.D. 2006, University of Zurich (H. Heimgartner). Current Position: Laboratory Head, Medicinal Chemistry, Actelion Pharmaceuticals, Ltd. (2010-present)

Wanlong Jiang, 2009-2010, Ph.D. 2000, Purdue University (P. Fuchs). Current Position: Neurocrine Biosciences (2010-present).

Annie Tam, 2008-2010, Ph.D. 2007, University of Wisconson-Madison (R. Raines). Current Position: Research Investigator, Bristol-Myers Squibb Process Development, Chemical Technology, New Brunswick, NJ (2010-present).

Cyrine Ezzili, 2006-2011, Ph.D. 2005, University of Parix XI (C. Mioskowski).

Yoshikazu Sasaki, 2007-2011, Ph.D. Kyoto University (N. Fuji). Current Position: Research Scientist, Shionogi, Kyoto, Japan (2011-present).

Peran Surakattula Murali Mohan Reddy, 2009-2012 Ph.D. IICT Hyderabad, India (A. Kamel). Current Position: Senior Research Scientist, Red Lion Scientifics, San Diego, CA (2012-present).

Cristine Crane, 2006-2008, 2009-2011, Ph.D. 2006, ETH (F. Diederich). Research Scientist, Vertex Pharmacueticals, San Diego, CA (2009). Current Position: Senior Chemist, L'Oreal USA, Clark, NJ, (2012-present).

Hiroaki Gotoh, JSP Fellowship, 2009-2011, Ph.D. 2009, Tokyo University of Science (A. B. Smith). Current Position: Assistant Professor, Yokohama University, Japan (2012-present).

Colin Skepper, NIH Postdoctoral Fellowship, 2010-2012, Ph.D. 2010, University of California, San Diego (T. Molinski). Current Position: Research Scientist, Novartis, Emeryville, CA (2012-present).

Joshua Pierce, NIH Postdoctoral Fellowship, 2009-2011, Ph.D. 2008, University of Pittsburgh (P. Wipf). Current Position: Associate Professor, North Carolina State University, Raleigh, NC (2011-present).

Yukihiro Itoh, 2011-2012, Ph.D. 2011, The University of Tokyo (Y. Hashimoto). Current Position: Assistant Professor, Kyoto University (2012-present).

Kristopher Boyle, 2008-2012, Ph.D. 2008, University of California, Irvine (L. Overman). Current Position: Associate Professor, Loma Linda University (2012-present).

Erick Leggans, 2010-2012, Ph.D. 2010, University of Minnesota (R. Fecik). Current Position: Assistant Professor of Chemistry, Grinnell College, Grinnell, IA (2012-present).

Nathan Werner, 2011-2012, Ph.D. 2011, University of Illinois at Urbana-Champaign (S. Denmark). Current Position: Associate Professor of Chemistry, Southern Utah University (2012-present).

Kristin Schleicher, 2010-2012, Ph.D. 2010, Massachusetts Institute of Technology (T. Jamison). Current Position: Staff Scientist, Department of Medicinal Chemistry, Takeda, San Diego, CA (2012-present).

Dimitri Hirsch-Weil, 2010-2012, Ph.D. 2010, University of Florida (S. Hong). Current Position: Scientist, MicroMidas Company, Sacramento, CA (2012-present).

Anthony Lozama, 2011-2012, Ph.D. 2011, The University of Iowa (T. Prisinzano). Current Position: Research Scientist, Intelluctual Ventures Laboratory, Bellevue, WA (2012-present).

James Collins, 2011-2013, Ph.D. 2011, Imperial College, London (A. Armstrong). Current Position: Research Scientist, Ferring Research Institute, San Diego, CA (2013-present).

Joseph Pinchman, 2011-2013, Ph.D. 2011, Indiana University (D. R. Williams). Current Position: Research Investigator I Genomics Institute of the Novartis Research Foundation, San Diego, CA (2013-present)

Yam Poudel, 2011-2013, Ph.D. 2010, University of Utah (G. Keck). Current Postion: Investigator II Medicinal Chemistry, Bristol-Myers Squibb, Redwood City, CA (2013-present)

Tim Barker, NIH Postdoctoral Fellowship, 2011-2013, Ph.D. 2011, University of California, Irvine (E. Jarvo). Current Position: Associate Professor, College of Charleston Department of Chemistry, Charleston, SC (2013-present)

Kotaro Shibayama, 2012-2013, Ms.C. 2005, Tokyo Institute of Technology, Japan (K. Suzuki) Current Position: Associate Research Specialist, Odawara Research Center, Nippon Soda Company (2013-present)

Matthias Weiss, 2011-2013, Ph.D. 2011, ETH Zurich (E. Carreira) Current Position: Team Leader, Syngenta, Basel, Switzerland (2013-present)

R. Matthew Cross, ACS Postdoctoral Fellowship, 2011-2013, Ph.D. University of South Florida (R. Manetsch) Current Position: Medical Scientific Manager at Allergan (2013-present)

Theo Michels, 2012-2014, Ph.D. University of California, Irvine (C. Vanderwal) Current Position: Research Scientist I at eFFECTOR Therapeutics (2014-present)

Yuan Liu, 2010-2014, Ph.D. University of California, San Diego (B. Moore). Current Position: Research Scientist at wellspring pharmaceutical (2014-present)

Atshushi Nakayama, 2012-2014, Ph.D. Chiba University  (H. Takayama). Current Position: Assistant Professor at Tokushima University Department of Pharmaceutical Science (2014–present)

Simon Kessler,  Swiss NSF Postdoctoral Fellowship, 2013-2015, Ph.D. University of Basel (H. Wegner).

Alex Schammel, 2012-2014, Ph.D. University of California, Los Angeles (N. Garg). Medicinal Chemist, Sirenas Marine Discovery (2014–2019). Current Position: Scientist II, Proneurotech (2019-Present). 

Adam Duerfeldt,  ACS Postdoctoral Fellowship, 2012-2014, Ph.D. University of Kansas (B. Blagg) Current Position: Assistant Professor at University of Oklahoma (2014–present)

Yukitaka Uematsu, 2012-2014, Ph.D 2006, visiting scientist, Kyoto University (K. Maruoka) Current Position: Research Scientist, Otsuka Pharmaceuticals (2006-present)

Mika Uematsu, 2012-2014, M.S. 2003, Kyoto University Current Position: Research Scientist, Otsuka Pharmaceuticals (2006-present)

Huijun Dong, 2013-2014, Ph.D. 2011, University of Illinois at Chicago (T. Driver) Current Position: Senior Scientist, Pfizer inc. (2014-present)

Jerry Feng, 2014-2015, Ph.D. 2014, Penn State (G. Chen and S. Weinreb), Current Position: Senior Scientist, Pfizer inc. (2015-present)

Jocelyn Wang, 2013-2015, Ph.D. 2011, University of California, Irvine (L. Overman) Current Position: Scientist at Janssen Research & Development, Johnson & Johnson. (2015-present)

Yiyun Yu, 2013-2015, Ph.D. 2013, University of Minnesota (G. Georg) Current Position: Senior Scientist,  AbbVie. (2015-present)

Kiyoun Lee, 2013-2015, Ph.D. 2012, Duke University (J. Hong) Current Position: Assistant Professor, The Catholic University of Korea (2015-present)

Kaicheng Zhu, 2013-2015, Ph.D. 2012, Boston University (J. Panek) Current Position: Senior Scientist, Pfizer Inc. (2015-present)

Erick Lindsey, 2013-2015, Ph.D. 2013, North Carnolina State University (C. Melander) Current Position: Research Scientist, Arcas Biosciences (2015-present)

Sankar Kuppusamy, 2011-2015, Ph.D. 2007, National Chemical Laboratory, University of Pune, India (M. K. Gurjar) Current Position: Senior Research Investigator, Biocon-BMS, Banglore (2015-present)

Daniel Carney 2014-2016, Ph.D. 2014, Brown University (J. Sello). Scientist 1, Ferring Pharmaceuticals (2016-2018). Current Position: Sr. Scientist, GI Chemistry, Takeda, San Diego (2018-present)

Matthew Morin 2010-2016, Ph.D. 2010, University of California, Irvine (Rychnovsky) Current Position: Scientist at Pharmacyclics (2016-present)

Youqian Deng 2014-2016, Ph.D., Zhejiang University, China (S. Ma)

Takasuke Mukaiyama 2014-2016, Ph.D. 2014, Tohoku University, Japan (Y. Hayashi) Current Position: Research Scientist I at eFFECTOR Therapeutics (2016-present)

Kejia (Derek) Wu 2013-2017, Ph.D. 2013, Shanghai Institute of Organic Chemistry (L-X. Dai, S-L. You) Current Position: Scientist, Medicinal Chemistry at ORIC Pharmaceuticals, Inc (2017-present)

Akinori Okano 2010-2017, Ph.D. 2010, Kyoto University (N. Fujii, H. Ohno) Scientist I, FLX Bio, Inc. (2017-2018). Current Position: Scientist II, Pharmacyclics (2018-Present). 

Brian Jones 2014-2017, Ph.D. 2014, Northwestern University (R. Thomson) Current Position: Senior Research Scientist at IDEAYA Biosciences (2017-present)

Oliver Allemann 2015-2017, Ph.D. 2014, University of Zurich (J. Siegel)

Prem Chanda 2013-2017, Ph.D. 2013, Purdue University (P. Ramachandran) Current Position: Assistant Professor of Chemistry, Southeastern Louisiana University (2017-present) 

John Lukesh 2014-2017, Ph.D. 2014, University of Wisconsin-Madison (R. Raines) Current Position: Assistant Professor of Chemistry, Wake Forest University (2017-present)

Srijana Ghimire 2015-2017, Ph.D. 2014, Purdue University (D. McMillin)

Richard Steel 2014-2017, Ph.D. 2014, University of East Anglia, Norwich (M. Searcey), Current Position: Senior Research Scientist at IDEAYA Biosciences (2017-Present)

Elizabeth Jacobs 2014-2017, Ph.D. 2014, University of East Anglia, Norwich (S. Lancaster), Current Position: Clinical Research Coordinator, Stanford University School of Medicine (2018-Present). 

Shouliang Yang 2014-2017, Ph.D. Peking University, China (Z. Yang), Current Position: Senior Scientist at Pfizer, La Jolla.

Yusuke Endo 2016-2018, Ph.D. 2015, Kumamoto University (M. Otsuka), Current Position: Research Scientist at Kaken Pharmaceutical Co., Ltd. (2018-Present)

Yuto Mifune 2016-2017, Ph.D. 2016, Tokyo Institute of Technology (H. Tanaka, S. Fuse), Current Position: Research Scientist at Mitsubishi Tanabe Pharma (2018-Present)

Shinji Tadano 2017-2019, Ph.D. 2017, Kumamoto University (H. Ishikawa), Current Position: Research Scientist at Sekisui Medical Co., Ltd. (2019-Present)

Christopher Gartshore 2017-2019, Ph.D. 2014, Monash University (D. Lupton), Current Position: Scientist PET Chemistry at Janssen Pharmaceuticals (2019-Present)

Byron Boon 2017-2019, Ph.D. 2017, University of California, Los Angeles (C. Merlic), Current Position: Scientist - Medicinal Chemistry, Neurocrine Biosciences (2019-Present)

Yuzo Mogi 2018-2019, Ph.D. 2015, Kyoto University (K. Takasu), Current Position: Research Scientist at Nippon Chemiphar, Co., Ltd., Saitama, Japan (2019-Present)

Nicholas Isley 2015-2019, Ph.D. 2015, University of California, Santa Barbara (B. Lipshutz), Current Position: Scientist - Chemistry, Erasca (2019-Present)

Shiwei (Steven) Qu 2016-2019, Ph.D. 2014, Peking University (T. Ye, Z-S. Xu), Current Position: Scientist - Medicinal Chemistry, Arcus Biosciences, Hayward, CA (2019-Present)

Satoshi Umezaki 2017-2019, Ph.D. 2012, University of Tokyo (T. Fukuyama), Current Position: UBE Industries (2019-Present)

Yu Cai 2017-2020, Ph.D. 2017, Brigham Young University (S. L. Castle), Current Position: Investigator, Shenzhen Bay Laboratory, Shenzhen, China (2020-Present).

Brittany Smolarski 2016-2020, B.S. 2016, California Lutheran University (J. Kingsbury), Current Position: Law Student, University of San Diego (2020-Present)

Jelena Momirov 2017-2020, B.S. 2017, Barry University (J. Boulos), Current Position: Graduate Student in Biology, Boston College (2020-Present)

Anushka Galasiti-Kankanamalage 2017-2020, Ph.D. 2017, Wichita State University (W. C. Groutas), Current Position: Scientist 1, Vertex, La Jolla, CA (2020-present)

Srinivas Paladugu 2019-2020, Ph.D. 2019, University of Utah (R. Looper), Current Position: Scientist, Arcus Biosciences, Hayward, CA (2020-present)

Jingjie Li 2019-2020, Ph.D. 2018, Peking University (Z. Yang)

Rosa Al-Herbawi 2020-2021, B.S. 2019, University of Massachusetts, Amnerst. Current Position: Research Assistant, Petrascheck Lab (2021-present)

Ceheng Tan 2017-2021, Ph.D. 2016, Peking University (Z. Yang). Current Position:

Rachel Gillard 2019-2021, Ph.D. 2019, Monash University (D. Lupton). Current Position: Research Scientist, Ferring Pharmaceuticals, La Jolla, CA.

Anindya Sarkar 2017-2021, Ph.D. 2017, Purdue University (A. K. Ghosh). Current Position: Research Scientist, BlossomHill Therapeutics, Inc., La Jolla, CA.

D. Jamin Keith 2019-2022, Ph.D. 2019, Vanderbilt University (S. Townsend). Current Position: Scientist, Janssen Pharmaceutica, La Jolla, CA.

Ming-Hsiu Yang 2017-2022, Ph.D. 2017, University of Kansas (R. Altman). Current Position: Postdoctoral Fellow, Texas A&M University.

Naoto Yamasaki 2021-2023, Ph.D. 2018, Tokushima Bunri University (H. Yamamoto and H. Imagawa). Current Position: Assistant Professor, Nagoya University.

Pengjin Qin 2020-2024, Ph.D. 2020, University of California, San Diego (J. O'Connor). Current Position: N/A